BIG1 — Bio-Gate AG Income Statement
0.000.00%
Last trade - 00:00- €7.67m
- €7.50m
- €7.05m
- 38
- 16
- 15
- 10
Annual income statement for Bio-Gate AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 5.13 | 6.24 | 5.99 | 7.25 | 7.05 |
| Cost of Revenue | |||||
| Gross Profit | 3.07 | 3.83 | 3.58 | 3.88 | 4.14 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 5.95 | 6.77 | 7.77 | 8.84 | 8.66 |
| Operating Profit | -0.818 | -0.537 | -1.78 | -1.59 | -1.61 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -0.84 | -0.56 | -1.81 | -1.64 | -1.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.841 | -0.562 | -1.81 | -1.64 | -1.66 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.805 | -0.544 | -1.81 | -1.62 | -1.62 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.805 | -0.544 | -1.81 | -1.62 | -1.62 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.103 | -0.07 | -0.22 | -0.19 | -0.18 |
| Dividends per Share |